Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Gynecologic 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Ovarian Neoplasms 1Melanoma 1Endometrial Neoplasms 1Chondrosarcoma 1Carcinosarcoma 1Carcinoma, Endometrioid 1

Interventions

pembrolizumab 11Nivolumab 4Erlotinib Hydrochloride 3Docetaxel 3Cetuximab 3Capecitabine 3tislelizumab 2spartalizumab 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Immunoglobulin G 2Gemcitabine 2Filgrastim 2Cyclophosphamide 2tremelimumab 1sargramostim 1ribociclib 1poly ICLC 1pexidartinib 1mirabegron 1futibatinib 1etoposide phosphate 1entinostat 1durvalumab 1ciforadenant 1cemiplimab 1capivasertib 1bempegaldesleukin 1avelumab 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Squamous Cell Carcinoma of Head and Neck × capivasertib × Sarcoma × Clear all
NCT05039801 2026-04-15

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡